000790.SZ
华神科技
SZSE · Healthcare · C 制造业 · CN
CNY 4.02
−1.47%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 527.9M | 545.5M | 864.0M | 1.0B | 873.1M |
| Cost of Revenue | 281.7M | 285.8M | 428.2M | 607.2M | 522.9M |
| Gross Profit | 246.2M | 259.7M | 435.7M | 396.2M | 350.2M |
| Operating Expenses | |||||
| R&D Expense | 23.1M | 23.4M | 28.2M | 31.9M | 25.2M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 89.0M | 87.2M | 90.3M | 92.0M | 95.2M |
| Selling & Marketing Expense | 206.6M | 240.6M | 281.7M | 215.0M | 168.6M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 348.1M | 381.2M | 434.1M | 362.5M | 301.3M |
| Cost and Expenses | 629.8M | 667.0M | 862.4M | 969.7M | 824.2M |
| Operating Income (EBIT) | (317.6M) | (334.8M) | 4.8M | 29.0M | 39.2M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (320.1M) | (337.0M) | 2.9M | 29.3M | 41.7M |
| Income Tax Expense | 10.5M | 9.1M | 10.3M | (329.4K) | 7.8M |
| Bottom Line | |||||
| Net Income | (303.4M) | (320.4M) | (6.7M) | 27.7M | 41.2M |
| Earnings from Cont. Ops | (330.7M) | (346.1M) | (7.4M) | 29.6M | 33.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (303.4M) | (320.4M) | (6.7M) | 27.7M | 41.2M |
| Per Share | |||||
| Basic EPS | (CN¥0.48) | (CN¥0.51) | (CN¥0.01) | CN¥0.04 | CN¥0.07 |
| Diluted EPS | (CN¥0.48) | (CN¥0.51) | (CN¥0.01) | CN¥0.04 | CN¥0.07 |
| Revenue Per Share | CN¥0.85 | CN¥0.87 | CN¥1.29 | CN¥1.45 | CN¥1.48 |
| Shares | |||||
| Basic Shares Outstanding | 619.8M | 628.3M | 669.0M | 691.5M | 588.8M |
| Diluted Shares Outstanding | 619.8M | 628.3M | 669.0M | 691.5M | 588.8M |
| Profitability Metrics | |||||
| EBITDA | — | (287.0M) | 47.8M | 63.0M | 71.4M |
| D&A | — | 47.8M | 43.1M | 34.1M | 32.2M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026